Approval · Notice of Compliance 27609 · 2022
KINOX: Notice of Compliance 27609
Issued February 16, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27609
- Date
- February 16, 2022
- Company
- Airgas Therapeutics, LlcPlumsteadville, Pennsylvania, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Manufacturer Name Change
- Canadian reference product
- INOMAX (Ino Therapeutics)
Products in this notice
Medicinal ingredients
- NITRIC OXIDE 100 PPM per CYLR
- NITRIC OXIDE 800 PPM per CYLR